Correction to: d-Amphetamine Transdermal System in Treatment of Children and Adolescents with ADHD

This is a correction notice to a previously published clinical trial examining d-amphetamine transdermal delivery for ADHD treatment in pediatric populations. The correction addresses secondary endpoint results and post-hoc effect size analyses from the original pivotal trial study.